Key result
Severe COVID-19 recovery is linked to a ~13% reduction in mid-RV diameter at follow-up.
Why the study?
The natural history of cardiac manifestations determined by advanced transthoracic echocardiography in multiethnic patients hospitalised with COVID-19 was unknown.
Observational (n=117)
No
Answers are grounded in this paper and cite their sources.
In survivors of COVID-19 hospitalization, pulmonary hemodynamics improve over time, but subclinical left and right ventricular impairment often persists at 17 months.
Purpose To determine the natural history of the cardiac manifestations, determined by advanced transthoracic echocardiography (TTE), due to COVID-19 in multiethnic hospitalised patients. Methods A prospective observational study, in a London NHS Trust, of patients admitted with COVID-19 undergoing TTE. Baseline TTE was taken during acute admission with follow-up TTE at a median of 17.6 months to assess the same left ventricular (LV), right ventricular (RV) and pulmonary pressure parameters with additional 3D and strain measures. Results There were a total of 117 patients with admission and follow-up TTE. LV parameters were largely unchanged at follow-up except E/A ratio decreasing from 0.98 to 0.85. LV global longitudinal strain measures detected subclinical LV impairment in 36% of patients. RV dimensions improved (mean mid RV diameter, 3.1 cm to 2.7 cm ( p < 0.001)) but with persistence of RV impairment at follow-up (28%). 3D RV ejection fraction and global strain measures determined impairment in around 40% of patients. All pulmonary haemodynamic measures showed improvement with resolution of effects of RV afterload ( p = 0.016), decrease in pulmonary artery systolic pressure (36 mmHg to 28 mmHg p = 0.032) and improvements in mean pulmonary valve acceleration time (113 ms to 120 ms), p = 0.025, and pulmonary vascular resistance (2.2 to 1.7 WU), p = 0.01. Conclusion Follow-up echocardiographic parameters compared to admission parameters of multiethnic hospitalised patients with COVID-19 demonstrate improved pulmonary haemodynamics but persistent LV and RV impairment which suggest possible myocarditic/microthrombotic lasting effects of COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Bioh et al. (2026) conducted an observational in COVID-19 (n=117). COVID-19 recovery vs. Acute COVID-19 admission (baseline) was evaluated on Mean mid right ventricular (RV) diameter in cm (p=<0.001). At a median follow-up of 17.6 months, hospitalized COVID-19 survivors showed improved right ventricular dimensions and pulmonary hemodynamics, despite persistent subclinical ventricular impairment.
Synapse has enriched 10 related papers. Consider them for comparative context: